Skye Bioscience Inc (SKYE)
5.53
+0.21
(+3.95%)
USD |
NASDAQ |
Nov 14, 16:00
5.53
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Price to Book Value: 2.304 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 2.217 |
| November 12, 2024 | 2.246 |
| November 11, 2024 | 2.292 |
| November 08, 2024 | 2.379 |
| November 07, 2024 | 2.267 |
| November 06, 2024 | 2.238 |
| November 05, 2024 | 2.229 |
| November 04, 2024 | 2.267 |
| November 01, 2024 | 2.317 |
| October 31, 2024 | 2.183 |
| October 30, 2024 | 2.121 |
| October 29, 2024 | 2.175 |
| October 28, 2024 | 2.146 |
| October 25, 2024 | 2.096 |
| October 24, 2024 | 2.033 |
| October 23, 2024 | 2.167 |
| October 22, 2024 | 2.058 |
| October 21, 2024 | 1.963 |
| October 18, 2024 | 1.929 |
| October 17, 2024 | 1.763 |
| October 16, 2024 | 1.783 |
| October 15, 2024 | 1.750 |
| October 14, 2024 | 1.704 |
| October 11, 2024 | 1.788 |
| October 10, 2024 | 1.558 |
| Date | Value |
|---|---|
| October 09, 2024 | 1.558 |
| October 08, 2024 | 1.613 |
| October 07, 2024 | 1.600 |
| October 04, 2024 | 1.479 |
| October 03, 2024 | 1.492 |
| October 02, 2024 | 1.488 |
| October 01, 2024 | 1.538 |
| September 30, 2024 | 1.629 |
| September 27, 2024 | 1.563 |
| September 26, 2024 | 1.650 |
| September 25, 2024 | 1.621 |
| September 24, 2024 | 1.671 |
| September 23, 2024 | 1.454 |
| September 20, 2024 | 1.308 |
| September 19, 2024 | 2.288 |
| September 18, 2024 | 2.183 |
| September 17, 2024 | 2.200 |
| September 16, 2024 | 2.417 |
| September 13, 2024 | 2.500 |
| September 12, 2024 | 2.500 |
| September 11, 2024 | 2.646 |
| September 10, 2024 | 2.913 |
| September 09, 2024 | 2.646 |
| September 06, 2024 | 2.433 |
| September 05, 2024 | 2.525 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.308
Minimum
Sep 20 2024
104.35
Maximum
Mar 09 2021
17.27
Average
6.037
Median
Apr 18 2024
Price to Book Value Benchmarks
| Oramed Pharmaceuticals Inc | 0.5365 |
| Viking Therapeutics Inc | 6.563 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.8831 |
Price to Book Value Related Metrics
| PS Ratio | 413.98 |
| Price | 5.53 |
| Earnings Yield | -70.67% |
| Market Cap | 167.77M |